|
|
X4 Pharmaceuticals Inc (NASDAQ: XFOR) |
|
|
|
| |
X4 Pharmaceuticals Inc Net Income per Employee
XFOR's Quarterly Results, Trends, Rankings, Statistics
X4 Pharmaceuticals Inc's Income per employee grew in the first quarter 2025 on a trailing twelve month basis to , the contribution of X4 Pharmaceuticals Inc's employees, reached a new high of $ 339,488income per employee. The Healthcare sector has seen employees of 7 other companies achieving higher income per employee. While X4 Pharmaceuticals Inc's total ranking has deteriorated compared to the previous quarter from 0 to 328.
What is Income per Employee Ratio?
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| XFOR Net Income per Employee |
(Mar 31 2025)
I. Quarter |
(Dec 31 2024)
IV. Quarter |
(Sep 30 2024)
III. Quarter |
(Jun 30 2024)
II. Quarter |
(Mar 31 2024)
I. Quarter |
| Y / Y Net Income Change |
- |
- |
- |
- |
- |
| Net Income per Employee (TTM) $ |
339,488 |
-870,930 |
1,535 |
-440,698 |
-3,111,698 |
| XFOR's Total
Ranking |
# 328 |
# 0 |
# 2118 |
# 0 |
# 0 |
| Seq. Net Income Change |
- |
- |
- |
- |
- |
| Net Income per Employee Statistics |
| High |
Average |
Low |
| $ 339,488 |
$ -1,550,041 |
$ -3,111,698 |
| (Mar 31 2025) |
|
(Mar 31 2024) |
| Companies with similar Income per Employee for 12 month ending Mar 31 2025, within Healthcare Sector | Income per Employee | Income 12 month ending Mar 31 2025 | Number of Employees Mar 31 2025 | | Bluebird Bio Inc | 562,250.00 | $ 139.438 Million | 248 | | Protagonist Therapeutics inc | 501,723.21 | $ 56.193 Million | 112 | | Hims and Hers Health Inc | 413,052.76 | $ 164.395 Million | 398 | | Perspective Therapeutics Inc | 404,190.48 | $ 8.488 Million | 21 | | Stoke Therapeutics Inc | 392,750.00 | $ 50.272 Million | 128 | | Acadia Pharmaceuticals Inc | 382,747.49 | $ 228.883 Million | 598 | | Corcept Therapeutics Inc | 376,440.34 | $ 132.507 Million | 352 | | Cytomx Therapeutics Inc | 346,691.67 | $ 41.603 Million | 120 | | Tenax Therapeutics Inc | 339,516.00 | $ 3.395 Million | 10 | | X4 Pharmaceuticals Inc | 339,488.37 | $ 14.598 Million | 43 | | Regeneron Pharmaceuticals Inc | 334,520.45 | $ 4,499.300 Million | 13,450 | | Gilead Sciences Inc | 331,388.89 | $ 5,965.000 Million | 18,000 | | Entera Bio Ltd | 313,838.71 | $ 9.729 Million | 31 | | Lantheus Holdings Inc | 304,941.25 | $ 254.321 Million | 834 | | Lipocine Inc | 299,653.06 | $ 4.794 Million | 16 | | Tg Therapeutics Inc | 296,590.91 | $ 39.150 Million | 132 | | Rigel Pharmaceuticals Inc | 275,392.59 | $ 37.178 Million | 135 | | Progyny Inc | 266,482.23 | $ 52.497 Million | 197 | | Eli Lilly And Company | 258,288.37 | $ 11,106.400 Million | 43,000 | | Transmedics Group Inc | 252,314.43 | $ 48.949 Million | 194 | | Castle Biosciences Inc | 245,591.46 | $ 40.277 Million | 164 | | Synlogic Inc | 243,485.71 | $ 8.522 Million | 35 | | Merck and Co Inc | 242,375.00 | $ 17,451.000 Million | 72,000 | | Dariohealth Corp | 235,784.21 | $ 44.799 Million | 190 | | Neurocrine Biosciences Inc | 218,428.57 | $ 305.800 Million | 1,400 | | Edwards Lifesciences Corporation | 210,863.64 | $ 4,175.100 Million | 19,800 | | Minerva Neurosciences Inc | 201,764.45 | $ 6.255 Million | 31 | | Biogen Inc | 195,416.12 | $ 1,479.300 Million | 7,570 | | Inspire Medical Systems inc | 188,402.27 | $ 66.506 Million | 353 | | Intuitive Surgical Inc | 182,348.64 | $ 2,493.800 Million | 13,676 |
Date modified: 2025-05-23T09:22:02+00:00
|
